NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Nuclear factor-kappa B (NF-kappaB) is a critical transcription factor involved in cellular responses.
• Dysregulation of NF-kappaB is implicated in the development and progression of various cancers, including gastrointestinal carcinomas.
• NF-kappaB activation is linked to chemoresistance, tumor growth, and inhibition of apoptosis.

Purpose of the Study:

• To elucidate the multifaceted role of NF-kappaB in the context of cancer treatment.
• To explore the potential of targeting NF-kappaB as a therapeutic strategy for gastrointestinal carcinomas.
• To review literature on NF-kappaB's involvement in chemoresistance, tumor suppression, and apoptosis.

Main Methods:

• Systematic literature search of the Pubmed database up to October 2004.
• Keywords used included 'gastrointestinal carcinoma,' 'NF-kappaB,' 'inhibitor,' 'cancer treatment molecular target,' and 'chemoresistance.'
• Review and synthesis of findings regarding NF-kappaB activation in chemoresistance, tumor growth, and apoptosis.

Main Results:

• NF-kappaB activation was found to be significantly involved in chemoresistance in gastrointestinal carcinomas.
• The role of NF-kappaB in promoting tumor growth and suppressing apoptosis was highlighted.
• Several potential strategies for inhibiting NF-kappaB activation were identified.

Conclusions:

• Targeting NF-kappaB activation represents a viable therapeutic approach for gastrointestinal carcinomas.
• Inhibiting NF-kappaB may overcome chemoresistance and enhance treatment efficacy.
• Further research into NF-kappaB inhibitors is warranted for clinical application in cancer therapy.